Showing Results : 1-1 of 1
Sort By :
  • LATEST MANUSCRIPTS IN Journal of Immunotherapy and Precision Oncology
  • Daniel Vargas P de Almeida, Justine M Anderson, Daniel C Danila, Michael J Morris, Susan F Slovin, Wassim Abida, Erica D Cohn, Raymond E Baser, Howard I Scher, Karen A Autio. Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer. Journal of immunotherapy and precision oncology. 2023, 6 (4): 162-169
    Cited : 0
    Read More
  • Hasan Cagri Yildirim, Fatih Kus, Deniz Can Guven, Ece Karaca, Yunus Kaygusuz, Omer Dizdar, Sercan Aksoy, Mustafa Erman, Suayib Yalcin, Saadettin Kilickap. Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab. Journal of immunotherapy and precision oncology. 2023, 6 (4): 170-176
    Cited : 0
    Read More
  • Ugochi Ebinama, Ajay Sheshadri, Kartik Anand, Iyer Swaminathan. Pulmonary Immune-Related Adverse Events of PD-1 Versus PD-L1 Checkpoint Inhibitors: A Retrospective Review of Pharmacovigilance. Journal of immunotherapy and precision oncology. 2023, 6 (4): 177-184
    Cited : 0
    Read More
  • Andrés F Cardona, Vaneza Ávila, Oscar Arrieta. Treatment for Advanced Non-Small Lung Cancer (NSCLC) with Mutated in Low- and Middle-Income Countries (LMICs). Journal of immunotherapy and precision oncology. 2023, 6 (4): 185-186
    Cited : 0
    Read More
  • Lydia Melissourgou-Syka, Michael A Gillespie, Sean M O'Cathail, Owen J Sansom, Colin W Steele, Campbell S D Roxburgh. A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer. Journal of immunotherapy and precision oncology. 2023, 6 (4): 187-197
    Cited : 0
    Read More
  • Daniel Huff, Shannon Fortin Ensign, Margaret S Ryan, Jeanne Palmer, Javier Munoz. Histiocytic Sarcoma Treated with Pembrolizumab: A Case Report and Literature Review. Journal of immunotherapy and precision oncology. 2023, 6 (4): 198-202
    Cited : 1
    Read More
  • . Erratum to "Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature" by Soto et al. Journal of immunotherapy and precision oncology. 2023, 6 (4): 203
    Cited : 0
    Read More
  • Andrea Castro, Aaron M Goodman, Zachary Rane, James V Talwar, Garrett M Frampton, Gerald P Morris, Scott M Lippman, Xinlian Zhang, Razelle Kurzrock, Hannah Carter. Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse. Journal of immunotherapy and precision oncology. 2023, 6 (3): 127-132
    Cited : 0
    Read More
  • Khanh Toan Nguyen, To Ta Van. Treatment of Stage IV Non-Small Cell Lung Cancer with Pembrolizumab in Combination with Platinum-Based Doublet Chemotherapy in Vietnam. Journal of immunotherapy and precision oncology. 2023, 6 (3): 133-140
    Cited : 0
    Read More
  • Mousa Alali, Maher Saifo. Optimizing the Treatment for Advanced Non-Small-Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor in Low-Income Countries: A Review. Journal of immunotherapy and precision oncology. 2023, 6 (3): 140-149
    Cited : 2
    Read More
  • Maluki Radford, Hassan Abushukair, Stijn Hentzen, Ludimila Cavalcante, Anwaar Saeed. Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era. Journal of immunotherapy and precision oncology. 2023, 6 (3): 150-157
    Cited : 0
    Read More
  • Anca Chelariu-Raicu, Sarina A Piha-Paul, Mariana Chavez-MacGregor, Jason Johnson, Raymond Sawaya, Mary Frances McAleer, Alissa Nguyen, Audrey Hartnett, Apostolia M Tsimberidou, Funda Meric-Bernstam, Ecaterina E Dumbrava. Multidisciplinary Care of a Large Brain Metastasis in a Patient with Hormone-Receptor-Positive Breast Cancer with Ataxia-Telangiectasia Mutation. Journal of immunotherapy and precision oncology. 2023, 6 (3): 158-161
    Cited : 0
    Read More
  • Juan I Ruiz, Maria A Lopez-Olivo, Yimin Geng, Maria E Suarez-Almazor. COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review. Journal of immunotherapy and precision oncology. 2023, 6 (2): 103-110
    Cited : 0
    Read More
  • Felipe Soto, Luis F Torre-Sada, Frank E Mott, Sang T Kim, Roza Nurieva, Vickie R Shannon, Saadia A Faiz, Roberto F Casal, Mehmet Altan, Julie Lin, Ajay Sheshadri. Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature. Journal of immunotherapy and precision oncology. 2023, 6 (2): 111-116
    Cited : 2
    Read More
  • Khalid Balaraj. Abstracts Presented at the 2022 Emirates Oncology Conference: November 25-27, 2022, Abu Dhabi, United Arab Emirates. Journal of immunotherapy and precision oncology. 2023, 6 (2): 117-126
    Cited : 0
    Read More
 
 


Journal List
Links
Content Links
About Us

5921-57-i
0